Blue Owl Capital Inc. (OWL)
NYSE: OWL · Real-Time Price · USD
20.97
-0.48 (-2.24%)
Nov 4, 2024, 4:00 PM EST - Market closed

Company Description

Blue Owl Capital Inc. operates as an asset manager in the United States.

The company offers permanent capital base solutions that enables it to offer holistic framework of capital solutions to middle market companies, large alternative asset managers, and corporate real estate owners and tenants.

It also provides direct lending products that offer private credit products comprising diversified, technology, first lien, and opportunistic lending to middle-market companies; liquid credit; GP strategic capital products, which offers capital solutions, including GP minority stakes, GP debt financing, and professional sports minority stakes; and real estate products that focuses on acquiring triple net lease real estate by investment grade or creditworthy tenants.

It offers its solutions through permanent capital vehicles, as well as long-dated private funds. Blue Owl Capital Inc. is headquartered in New York, New York.

Blue Owl Capital Inc.
Blue Owl Capital logo
Country United States
Founded 2020
Industry Asset Management
Sector Financials
Employees 685
CEO Douglas Irving Ostrover

Contact Details

Address:
399 Park Avenue, 37th Floor
New York, New York 10022
United States
Phone 212 419 3000
Website blueowl.com

Stock Details

Ticker Symbol OWL
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001823945
CUSIP Number 09581B103
ISIN Number US09581B1035
Employer ID 86-3906032
SIC Code 6282

Key Executives

Name Position
Marc S. Lipschultz Co-Founder, Co-Chief Executive Officer and Director
Douglas Irving Ostrover Co-Founder, Chairman and Co-Chief Executive Officer
Michael Douglass Rees Co-Founder, Co-President, Head of Blue Owl's Dyal Capital Division and Director
Craig William Packer Head of Credit, Co-Founder, Co-President, Senior MD and Director
Marc Zahr Co-President and Director
Alan Jay Kirshenbaum CPA, CPA Chief Financial Officer
Sean Ward J.D. Senior MD and Director
Andrew Robert Polland Chief Operating Officer
Ann Dai MD and Head of Investor Relations
Neena Ann Reddy Chief Legal Officer, General Counsel and Secretary

Latest SEC Filings

Date Type Title
Oct 31, 2024 8-K Current Report
Oct 7, 2024 8-K Current Report
Sep 30, 2024 8-K/A [Amend] Current report
Sep 25, 2024 EFFECT Notice of Effectiveness
Sep 25, 2024 424B3 Prospectus
Sep 19, 2024 S-4/A Filing
Sep 16, 2024 UPLOAD Filing
Sep 10, 2024 S-4 Filing
Sep 10, 2024 8-K Current Report
Sep 3, 2024 144 Filing